Proviral location affects cognate peptide-induced virus production and immune recognition of HIV-1-infected T cell clones.


Journal

The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877

Informations de publication

Date de publication:
01 11 2023
Historique:
received: 03 04 2023
accepted: 06 09 2023
medline: 2 11 2023
pubmed: 12 9 2023
entrez: 12 9 2023
Statut: epublish

Résumé

BACKGROUNDHIV-1-infected CD4+ T cells contribute to latent reservoir persistence by proliferating while avoiding immune recognition. Integration features of intact proviruses in elite controllers (ECs) and people on long-term therapy suggest that proviruses in specific chromosomal locations can evade immune surveillance. However, direct evidence of this mechanism is missing.METHODSIn this case report, we characterized integration sites and full genome sequences of expanded T cell clones in an EC before and after chemoradiation. We identified the cognate peptide of infected clones to investigate cell proliferation and virus production induced by T cell activation, and susceptibility to autologous CD8+ T cells.RESULTSThe proviral landscape was dominated by 2 large clones with replication-competent proviruses integrated into zinc finger (ZNF) genes (ZNF470 and ZNF721) in locations previously associated with deeper latency. A third nearly intact provirus, with a stop codon in Pol, was integrated into an intergenic site. Upon stimulation with cognate Gag peptides, infected clones proliferated extensively and produced virus, but the provirus in ZNF721 was 200-fold less inducible. While autologous CD8+ T cells decreased the proliferation of cells carrying the intergenic provirus, they had no effect on cells with the provirus in the ZNF721 gene.CONCLUSIONSWe provide direct evidence that upon activation of infected clones by cognate antigen, the lower inducibility of intact proviruses in ZNF genes can result in immune evasion and persistence.FUNDINGOffice of the NIH Director and National Institute of Dental & Craniofacial Research; NIAID, NIH; Johns Hopkins University Center for AIDS Research.

Identifiants

pubmed: 37698927
pii: 171097
doi: 10.1172/JCI171097
pmc: PMC10617777
doi:
pii:

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI140789
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI094189
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI164570
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI149680
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI045008
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI129661
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI172542
Pays : United States
Organisme : NIH HHS
ID : DP5 OD031834
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI164566
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI117950
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA241762
Pays : United States

Références

Nat Commun. 2020 Aug 14;11(1):4089
pubmed: 32796830
JCI Insight. 2022 Nov 8;7(21):
pubmed: 36345940
Nature. 2023 Feb;614(7947):309-317
pubmed: 36599977
Mol Ther. 2020 Feb 5;28(2):352-356
pubmed: 31951833
PLoS Pathog. 2017 Mar 22;13(3):e1006283
pubmed: 28328934
Front Microbiol. 2019 Oct 01;10:2204
pubmed: 31632364
Cell. 2016 Aug 11;166(4):1004-1015
pubmed: 27453467
AIDS Res Hum Retroviruses. 1996 Dec 10;12(18):1691-8
pubmed: 8959245
Trends Genet. 2023 Apr;39(4):251-267
pubmed: 36754727
Elife. 2020 Oct 06;9:
pubmed: 33021198
Front Immunol. 2020 Apr 07;11:591
pubmed: 32318072
Immunity. 2008 Dec 19;29(6):1009-21
pubmed: 19062316
Proc Natl Acad Sci U S A. 2017 May 2;114(18):E3659-E3668
pubmed: 28416661
J Exp Med. 2006 May 15;203(5):1357-69
pubmed: 16682496
Nucleic Acids Res. 2022 Jul 5;50(W1):W774-W781
pubmed: 35412637
Immunity. 2012 Mar 23;36(3):491-501
pubmed: 22406268
JCI Insight. 2019 Jun 20;4(12):
pubmed: 31217357
JCI Insight. 2018 Sep 20;3(18):
pubmed: 30232278
Cell Rep. 2017 Oct 17;21(3):813-822
pubmed: 29045846
Viruses. 2021 Jun 25;13(7):
pubmed: 34202310
J Virol. 2020 Nov 9;94(23):
pubmed: 32907983
J Exp Med. 2017 Apr 3;214(4):959-972
pubmed: 28341641
J Virol. 2009 Apr;83(7):3407-12
pubmed: 19153230
Clin Infect Dis. 2021 Oct 5;73(7):e1973-e1981
pubmed: 33677480
Science. 1995 Dec 15;270(5243):1811-5
pubmed: 8525373
Carcinogenesis. 2018 Dec 13;39(11):1389-1398
pubmed: 30202955
Nat Med. 2021 Dec;27(12):2085-2098
pubmed: 34848888
Open Forum Infect Dis. 2022 Nov 19;9(12):ofac620
pubmed: 36519118
J Virol. 2004 Jun;78(12):6122-33
pubmed: 15163705
Proc Natl Acad Sci U S A. 2020 Aug 4;117(31):18692-18700
pubmed: 32690683
Viruses. 2020 Jan 25;12(2):
pubmed: 31991737
J Exp Med. 2021 Dec 6;218(12):
pubmed: 34636876
J Clin Invest. 2023 Feb 1;133(3):
pubmed: 36719383
J Clin Invest. 2020 Nov 2;130(11):5847-5857
pubmed: 33016926
Retrovirology. 2013 Dec 12;10:152
pubmed: 24330837
PLoS Pathog. 2021 Apr 7;17(4):e1009141
pubmed: 33826675
Trends Immunol. 2007 Dec;28(12):532-40
pubmed: 17981085
JCI Insight. 2023 Apr 10;8(7):
pubmed: 36821374
Nat Immunol. 2015 Jun;16(6):563-70
pubmed: 25988888
Cell Host Microbe. 2020 Apr 8;27(4):519-530
pubmed: 32272077
Nat Commun. 2021 Jun 17;12(1):3727
pubmed: 34140517
Immunity. 2007 Sep;27(3):406-16
pubmed: 17892849
Nature. 2014 Aug 7;512(7512):74-7
pubmed: 25042999
Annu Rev Genet. 2019 Dec 3;53:393-416
pubmed: 31518518
PLoS Pathog. 2020 Sep 17;16(9):e1008821
pubmed: 32941545
Nature. 2015 Feb 19;518(7539):317-30
pubmed: 25693563
Nat Med. 2003 Jun;9(6):727-8
pubmed: 12754504
J Clin Microbiol. 2019 Feb 27;57(3):
pubmed: 30626659
Sci Transl Med. 2021 Dec 15;13(624):eabl4097
pubmed: 34910552
Science. 1997 Nov 14;278(5341):1295-300
pubmed: 9360927
Cell Death Differ. 2014 Mar;21(3):381-7
pubmed: 24162661
Immunity. 2018 May 15;48(5):872-895
pubmed: 29768175
J Clin Invest. 2021 Jun 1;131(11):
pubmed: 34060478
Sci Transl Med. 2022 Jan 26;14(629):eabl3836
pubmed: 35080914
J Clin Invest. 2021 Feb 1;131(3):
pubmed: 33301425
PLoS Pathog. 2013;9(5):e1003398
pubmed: 23737751
J Clin Invest. 2019 Mar 1;129(3):988-998
pubmed: 30688658
PLoS One. 2014 Mar 17;9(3):e92118
pubmed: 24638072
Cell. 2022 Jan 20;185(2):266-282.e15
pubmed: 35026153
Nat Immunol. 2019 Aug;20(8):1059-1070
pubmed: 31308541
Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2308-12
pubmed: 7534418
Virus Res. 2012 Nov;169(2):324-39
pubmed: 22721779
J Exp Med. 2020 Jul 6;217(7):
pubmed: 32311008
Immunity. 2022 Jun 14;55(6):1013-1031.e7
pubmed: 35320704
Nat Med. 1995 Dec;1(12):1284-90
pubmed: 7489410
Nature. 2019 Feb;566(7742):120-125
pubmed: 30700913
J Clin Invest. 2016 Feb;126(2):455-63
pubmed: 26731469
Mol Ther Methods Clin Dev. 2016 Dec 18;4:39-49
pubmed: 28344990
Cell Host Microbe. 2023 Jan 11;31(1):83-96.e5
pubmed: 36596305
Nature. 2020 Sep;585(7824):261-267
pubmed: 32848246
J Infect Dis. 2015 Nov 1;212(9):1361-5
pubmed: 25877550
J Clin Invest. 2023 Mar 15;133(6):
pubmed: 36602866
EBioMedicine. 2020 Sep;59:102853
pubmed: 32654992
Sci Transl Med. 2015 Aug 19;7(301):301ra131
pubmed: 26290413
PLoS Pathog. 2022 Aug 31;18(8):e1010726
pubmed: 36044447
JCI Insight. 2021 Aug 23;6(16):
pubmed: 34228640
Nat Med. 2018 Jul;24(7):923-926
pubmed: 29892063
Retrovirology. 2011 Aug 03;8:63
pubmed: 21812985

Auteurs

Filippo Dragoni (F)

Department of Medicine.

Abena K Kwaa (AK)

Department of Medicine.

Caroline C Traut (CC)

Department of Medicine.

Rebecca T Veenhuis (RT)

Department of Molecular and Comparative Pathobiology, and.
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Bezawit A Woldemeskel (BA)

Department of Medicine.

Angelica Camilo-Contreras (A)

Department of Medicine.

Hayley E Raymond (HE)

Department of Microbiology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Arbor G Dykema (AG)

Bloomberg~Kimmel Institute for Cancer Immunotherapy, and.
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Eileen P Scully (EP)

Department of Medicine.

Amanda M Rosecrans (AM)

Department of Medicine.

Kellie N Smith (KN)

Bloomberg~Kimmel Institute for Cancer Immunotherapy, and.
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Frederic D Bushman (FD)

Department of Microbiology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Francesco R Simonetti (FR)

Department of Medicine.
Department of Molecular and Comparative Pathobiology, and.

Joel N Blankson (JN)

Department of Medicine.
Department of Molecular and Comparative Pathobiology, and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH